Presentations
2021
Antibiotic Resistance Research and Stewardship Conference, Virtual, January 26-28, 2021
2020
IDWeek, Virtual, October 21-25, 2020
Inhibitory Effect of Ursodeoxycholic Acid on Clostridioides difficile Growth
A Pharmacoepidemiologic Evaluation of Echinocandin Use
Evaluation of Clostridioides difficile Environmental Contamination Surrounding C. difficile Patients vs. non-C. difficile Patients in Outpatient Infusion Centers
A Novel Method to Assess Virulence of Clostridioides difficile: Focus on C. difficile Ribotype 106
Antifungal Resistant Candida glabrata Are Most Commonly Colonized in Clostridioides difficile Infection (CDI) Patient Guts in Texas
ACCP, Virtual, October 19-30, 2020
A Pharmacoepidemiologic Evaluation of Echinocandin Use
Anaerobe, Virtual, July 23-24 2020
Clostridioides difficile Ribotype Distributions Found in the Hospital Environment Versus Clinical Strains
Patients with Severe Clostridioides difficile Infection Have Increased Risk of Systemic Infections with Multidrug-Resistant Organisms
Antibiotic Resistance Research and Stewardship Conference, Houston, TX, January 22-24, 2020
A Single-Center Surveillance Study of Cystic Fibrosis Microbiological Cultures
Clinical Outcomes of Ribotype 106 Clostridioides difficile in a Tertiary Hospital
2019
IDWeek, Washington DC, October 2-6, 2019
Late Breaker Oral Abstract: (Kevin Garey) A Randomized, Blinded, Placebo- and Vancomycin-Controlled, First-In-Human (FIH) Study of the Safety, Pharmacokinetics (PK), and Fecal Microbiome Effects of ACX-362E, a Novel Anti-Clostridial DNA Polymerase IIIC (polIIIC) Inhibitor
Oral Abstract: (Anne Gonzales-Luna) Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile
In vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile
Isolation and Characterization of Candida auris From an Active Surveillance System in Texas
Molecular Characteristics of Environmental Clostridioides difficile From a Large Texas Hospital
Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
Clinical Outcomes Associated with an Emerging Clostridioides difficile Ribotype 255 in Texas
Serial Microbiome Analysis in a Patient with Multiple Failed Fecal Microbiome Transplantations
An Invertebrate Model to Study Gut Microbiome Dysbiosis
Society of Infectious Diseases Pharmacists (SIDP) Annual Meeting, Washington DC, October 1, 2019
Platform Oral Presentation: (Travis Carlson) Eosinopenia and Binary Toxin Increases Mortality in Hospitalized Patients with Clostridioides difficile Infection
ASM Microbe, San Francisco, California, June 20-24, 2019
A Retrospective Analysis of Ribotype Distributions Found in the Environment Versus Those Cultured from Clostridioides difficile Infected Patients
ECCMID, Amsterdam, Netherlands, April 13-16, 2019
Texas Statewide Surveillance of Clostridioides difficile Infection, 2011-2018
Antibiotic Resistance Research and Stewardship Conference, Houston, TX, January 23-25, 2019